These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30231904)

  • 41. Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS).
    Hendrickx N; Mentré F; Traschütz A; Gagnon C; Schüle R; ; ; Synofzik M; Comets E
    AAPS J; 2024 Apr; 26(3):57. PubMed ID: 38689016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and Molecular Findings of Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay: an Iranian Case Series Expanding the Genetic and Neuroimaging Spectra.
    Ashrafi MR; Mohammadi P; Tavasoli AR; Heidari M; Hosseinpour S; Rasulinejad M; Rohani M; Akbari MG; Malamiri RA; Badv RS; Fathi D; Dehnavi AZ; Savad S; Rabbani A; Synofzik M; Mahdieh N; Rezaei Z
    Cerebellum; 2023 Aug; 22(4):640-650. PubMed ID: 35731353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered synaptic and firing properties of cerebellar Purkinje cells in a mouse model of ARSACS.
    Ady V; Toscano-Márquez B; Nath M; Chang PK; Hui J; Cook A; Charron F; Larivière R; Brais B; McKinney RA; Watt AJ
    J Physiol; 2018 Sep; 596(17):4253-4267. PubMed ID: 29928778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and genetic variability among Bulgarian patients with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Chamova T; Ivanova N; Cherninkova S; Koleva M; Zlatareva D; Bojinova V; Mihova K; Georgiev M; Ferdinandov D; Bichev S; Kaneva R; Mitev V; Jordanova A; Tournev I
    Mol Genet Genomic Med; 2024 Jul; 12(7):e2483. PubMed ID: 39044368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MRI-ARSACS: An Imaging Index for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) Identification Based on the Multicenter PROSPAX Study.
    Scaravilli A; Negroni D; Senatore C; Ugga L; Cosottini M; Ricca I; Bender B; Traschütz A; Başak AN; Vural A; van de Warrenburg BP; Durr A; La Piana R; Timmann D; ; Schüle R; Synofzik M; Santorelli FM; Cocozza S
    Mov Disord; 2024 Aug; 39(8):1343-1351. PubMed ID: 38847051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is the ataxia of Charlevoix-Saguenay a developmental disease?
    Gazulla J; Vela AC; Marín MA; Pablo L; Santorelli FM; Benavente I; Modrego P; Tintoré M; Berciano J
    Med Hypotheses; 2011 Sep; 77(3):347-52. PubMed ID: 21665375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. POLR3A-related spastic ataxia: new mutations and a look into the phenotype.
    Infante J; Serrano-Cárdenas KM; Corral-Juan M; Farré X; Sánchez I; de Lucas EM; García A; Martín-Gurpegui JL; Berciano J; Matilla-Dueñas A
    J Neurol; 2020 Feb; 267(2):324-330. PubMed ID: 31637490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Documenting the psychometric properties of the scale for the assessment and rating of ataxia to advance trial readiness of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Bourcier D; Bélanger M; Côté I; Brais B; Synofzik M; Brisson JD; Rodrigue X; Gagnon MM; Mathieu J; Gagnon C
    J Neurol Sci; 2020 Oct; 417():117050. PubMed ID: 32736199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination.
    Chelban V; Patel N; Vandrovcova J; Zanetti MN; Lynch DS; Ryten M; Botía JA; Bello O; Tribollet E; Efthymiou S; Davagnanam I; ; Bashiri FA; Wood NW; Rothman JE; Alkuraya FS; Houlden H
    Am J Hum Genet; 2017 Jun; 100(6):969-977. PubMed ID: 28575651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A homozygous missense variant in the homeobox domain of the NKX6-2 results in progressive spastic ataxia type 8 associated with lower limb weakness and neurological manifestations.
    Almatrafi A; Umair M; Eldardear A; Al-Luqmani M; Hashmi JA; Albalawi AM; Alfadhel M; Ramzan K; Basit S
    J Gene Med; 2020 Aug; 22(8):e3196. PubMed ID: 32246862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical, ophthalmological, imaging and genetic features in Brazilian patients with ARSACS.
    Rezende Filho FM; Parkinson MH; Pedroso JL; Poh R; Faber I; Lourenço CM; Júnior WM; França Junior MC; Kok F; Sallum JMF; Giunti P; Barsottini OGP
    Parkinsonism Relat Disord; 2019 May; 62():148-155. PubMed ID: 30638817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): typical clinical and neuroimaging features in a Brazilian family.
    Pedroso JL; Braga-Neto P; Abrahão A; Rivero RL; Abdalla C; Abdala N; Barsottini OG
    Arq Neuropsiquiatr; 2011; 69(2B):288-91. PubMed ID: 21625752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Larivière R; Gaudet R; Gentil BJ; Girard M; Conte TC; Minotti S; Leclerc-Desaulniers K; Gehring K; McKinney RA; Shoubridge EA; McPherson PS; Durham HD; Brais B
    Hum Mol Genet; 2015 Feb; 24(3):727-39. PubMed ID: 25260547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Virtual Peg Insertion Test as an assessment of upper limb coordination in ARSACS patients: a pilot study.
    Gagnon C; Lavoie C; Lessard I; Mathieu J; Brais B; Bouchard JP; Fluet MC; Gassert R; Lambercy O
    J Neurol Sci; 2014 Dec; 347(1-2):341-4. PubMed ID: 25439167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Supratentorial and pontine MRI abnormalities characterize recessive spastic ataxia of Charlevoix-Saguenay. A comprehensive study of an Italian series.
    Prodi E; Grisoli M; Panzeri M; Minati L; Fattori F; Erbetta A; Uziel G; D'Arrigo S; Tessa A; Ciano C; Santorelli FM; Savoiardo M; Mariotti C
    Eur J Neurol; 2013 Jan; 20(1):138-46. PubMed ID: 22816526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ARSACS as a Worldwide Disease: Novel SACS Mutations Identified in a Consanguineous Family from the Remote Tribal Jammu and Kashmir Region in India.
    Kuchay RAH; Mir YR; Zeng X; Hassan A; Musarrat J; Parwez I; Kernstock C; Traschütz A; Synofzik M
    Cerebellum; 2019 Aug; 18(4):807-812. PubMed ID: 30963395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toward a Better Understanding of Walking Speed in Ataxia of Charlevoix-Saguenay: a Factor Exploratory Study.
    Lessard I; Hébert LJ; St-Gelais R; Côté I; Mathieu J; Brais B; Gagnon C
    Cerebellum; 2024 Aug; 23(4):1377-1385. PubMed ID: 38133849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia.
    Vermeer S; Meijer RP; Pijl BJ; Timmermans J; Cruysberg JR; Bos MM; Schelhaas HJ; van de Warrenburg BP; Knoers NV; Scheffer H; Kremer B
    Neurogenetics; 2008 Jul; 9(3):207-14. PubMed ID: 18465152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measurement properties of wheelchair use assessment tools in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Bourassa J; Best KL; Gagnon C; Hébert LJ; Brais B; Routhier F
    Disabil Rehabil Assist Technol; 2022 Nov; 17(8):907-915. PubMed ID: 32981404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two novel homozygous SACS mutations in unrelated patients including the first reported case of paternal UPD as an etiologic cause of ARSACS.
    Anesi L; de Gemmis P; Pandolfo M; Hladnik U
    J Mol Neurosci; 2011 Mar; 43(3):346-9. PubMed ID: 20852969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.